Company BioRestorative Therapies, Inc. Other OTC
Equities
BRTX
US0906554086
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Products and Medical Therapies
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +21.70% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +21.70% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01/18/01 |
Robert Kristal
DFI | Director of Finance/CFO | - | 04/21/04 |
Compliance Officer | 55 | 01/15/01 | |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13/11/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 29/21/29 |
David Rosa
BRD | Director/Board Member | 59 | 29/21/29 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13/11/13 |
Nickolay Kukekov
BRD | Director/Board Member | 49 | 18/21/18 |
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01/18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,398,158 | 0 | 0 | 81.20 % |
Stock B | 1 | 6,769,919 | 5,497,141 ( 81.20 %) | 0 |
Company contact information
BioRestorative Therapies, Inc.
40 Marcus Drive Suite 1
11747, Melville
+631 760 8100
http://www.biorestorative.comSector
1st Jan change | Capi. | |
---|---|---|
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |